IL1B and COVID-19: Direct correlations between COVID-19 outcomes and individual cytokines and immune cell populations indicate symptoms of COVID-19 are associated with elevations in interleukin 1 beta (IL-1β), IL-6, interleukin 10 (IL-10), and TNFα), as well as a general lymphopenia (47–49).